![benzoapyrene phase 2 glutathione s transferase Benzo[a]pyrene (BaP) metabolites predominant in human plasma following escalating oral micro-dosing with [14C]-BaP Mitigation of benzo(a)pyrene-induced hepatotoxicity and](https://ars.els-cdn.com/content/image/1-s2.0-S016041202100670X-ga1.jpg)
benzoapyrene phase 2 glutathione s transferase Benzo[a]pyrene (BaP) metabolites predominant in human plasma following escalating oral micro-dosing with [14C]-BaP Mitigation of benzo(a)pyrene-induced hepatotoxicity and
Mitigation of benzo(a)pyrene induced hepatotoxicity and oxidative damage in Nile tilapia (Oreochromis niloticus) using N acetylcysteine loaded starch nanoparticles in porous alginate beads through the CYP1A Nrf2 HO 1 pathway Aquaculture International Dynamic changes of DNA methylation induced by benzo(a)pyrene in cancer Genes and Environment Springer Nature Link Effects of combined exposures of microcystin LR and benzo[a]pyrene on detoxification in the fish liver cell line (PLHC 1) ScienceDirect ELECTROCHEMICAL DETECTION OF BENZO[A]PYRENE METABOLITE DNA DAMAGE : IMPLICATIONS OF NUCLEOBASE SEQUENCE AND ADDUCT STEREOCHEMISTRY Semantic Scholar Metabolic pathway of BaP benzo[a]pyrene (BaP), benzo[a]pyrene 7, Download Scientific Diagram Profile of benzo[a]pyrene metabolism. Major primary and secondary Download Scientific Diagram
Pay in 4 interest-free payments of $5.93 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
![benzoapyrene phase 2 glutathione s transferase Benzo[a]pyrene (BaP) metabolites predominant in human plasma following escalating oral micro-dosing with [14C]-BaP Mitigation of benzo(a)pyrene-induced hepatotoxicity and](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs10499-025-01884-2/MediaObjects/10499_2025_1884_Fig1_HTML.png)
![benzoapyrene phase 2 glutathione s transferase Benzo[a]pyrene (BaP) metabolites predominant in human plasma following escalating oral micro-dosing with [14C]-BaP Mitigation of benzo(a)pyrene-induced hepatotoxicity and](https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs41021-023-00278-1/MediaObjects/41021_2023_278_Fig2_HTML.png)
![benzoapyrene phase 2 glutathione s transferase Benzo[a]pyrene (BaP) metabolites predominant in human plasma following escalating oral micro-dosing with [14C]-BaP Mitigation of benzo(a)pyrene-induced hepatotoxicity and](https://ars.els-cdn.com/content/image/1-s2.0-S0166445X25002905-gr1.jpg)
![benzoapyrene phase 2 glutathione s transferase Benzo[a]pyrene (BaP) metabolites predominant in human plasma following escalating oral micro-dosing with [14C]-BaP Mitigation of benzo(a)pyrene-induced hepatotoxicity and](https://figures.semanticscholar.org/454ead816b5c1b5f4eb19d05a5d6244a04649098/20-Figure1.2-1.png)
![benzoapyrene phase 2 glutathione s transferase Benzo[a]pyrene (BaP) metabolites predominant in human plasma following escalating oral micro-dosing with [14C]-BaP Mitigation of benzo(a)pyrene-induced hepatotoxicity and](https://www.researchgate.net/publication/26332727/figure/fig3/AS:669332065513493@1536592608391/Metabolic-pathway-of-BaP-benzoapyrene-BaP-benzoapyrene-7.png)